Sitting “right in the center” of intensified computing power and new experimental methods lets Relay Therapeutics Inc. pursue its method of “bouncing between the virtual and physical world constantly,” CEO Sanjiv Patel told BioWorld, and could mean a powerful change in how drugs are developed, in cancer and beyond.